Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone

The outcome of patients with multiple myeloma is dictated primarily by cytogenetic abnormalities and proliferative capacity of plasma cells. We studied the outcome after initial therapy with lenalidomide-dexamethasone among 100 newly diagnosed patients, risk-stratified by genetic abnormalities and p...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Kapoor, Prashant, Kumar, Shaji, Fonseca, Rafael, Lacy, Martha Q., Witzig, Thomas E., Hayman, Suzanne R., Dispenzieri, Angela, Buadi, Francis, Bergsagel, P. Leif, Gertz, Morie A., Dalton, Robert J., Mikhael, Joseph R., Dingli, David, Reeder, Craig B., Lust, John A., Russell, Stephen J., Roy, Vivek, Zeldenrust, Steven R., Stewart, A. Keith, Kyle, Robert A., Greipp, Philip R., Rajkumar, S. Vincent
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society of Hematology 2009
Θέματα:
Clinical Trials and Observations
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2713462/
https://ncbi.nlm.nih.gov/pubmed/19324902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-01-202010
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια